Quick Results
In the News

James Burns Talks with Bloomberg BNA's Pharmaceutical Law & Industry Report About FTC Actions in Pay-for-Delay Cases

Share

In this Bloomberg BNA Pharmaceutical Law & Industry Report article, Jim Burns comments on the FTC being increasingly aggressive in seeking disgorgement from companies that profit from allegedly illegal drug patent litigation settlements.

Read the Article

Email Disclaimer

NOTICE: The mailing of this email is not intended to create, and receipt of it does not constitute an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.
Cancel Accept